KPV 5mg Peptide

KPV: a small peptide in intestinal research

KPV 5mg contains the three-amino-acid sequence Lys-Pro-Val. This sequence corresponds to the C-terminal region of alpha-melanocyte-stimulating hormone, linking KPV with research into how short peptide fragments influence inflammatory responses.

PepT1-mediated uptake

PepT1 is a transporter that carries small peptides into cells. A primary KPV study investigated this pathway in human-derived intestinal epithelial cells and T cells, reporting reduced NF-kappaB and MAP-kinase signalling alongside changes in inflammatory cytokine secretion.

The same research examined two chemically induced mouse colitis models and reported lower inflammatory readouts. This combination of transport, signalling and whole-animal experiments provides a coherent basis for studying KPV in intestinal inflammation.

Extending the experimental questions

Later mouse work explored KPV in inflammation-associated colorectal tumour models, examining the relationship between peptide transport and chronic inflammatory processes. These findings are preclinical and do not establish treatment or prevention of bowel disease or cancer in people.

Chemical form also matters: acetylated, amidated and palmitoylated KPV derivatives are separately specified materials. This listing retains the supplied KPV identity without assuming those modifications, keeping the research discussion tied to the named tripeptide.

Also known as / branded as

• Lys-Pro-Val
• Lysine-proline-valine
• Alpha-MSH(11-13) sequence